L02.619 Insurance Policy Changes

ICD-10 L02.619 is officially defined as "Cutaneous abscess of unspecified foot." code L02.619 is referenced in 8 tracked payer policy changes from Independence Blue Cross and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code L02.619 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Independence Blue Cross · Effective Oct 1, 2025Medium impact
MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross updated ICD-10 diagnosis codes for MA11.014h toe nail debridement policy effective 10/01/2025. Added E11.A (Type 2 diabetes in remission) to Attachment B and replaced the generic G35 (Multiple sclerosis) code with seven new MS-specific codes (G35.A through G35.D) in Attachment C. The policy coverage criteria and reimbursement methodology remain unchanged; only diagnosis code references were updated to align with new ICD-10 CM coding standards.
Independence Blue Cross · Effective Oct 1, 2025Medium impact
MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross updated ICD-10 diagnosis codes effective 10/01/2025 for policy MA11.014h covering nail debridement. One code (E11.A for Type 2 diabetes in remission) was added to qualifying systemic illness criteria, seven multiple sclerosis codes (G35.A, G35.B0-B2, G35.C0-C2, G35.D) replaced the single G35 code, and the generic G35 code was deleted. These changes align with updated CMS coding standards but do not modify coverage criteria or reimbursement.
Independence Blue Cross · Effective Oct 1, 2025Medium impact
11.08.17l, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails
Independence Blue Cross reissued Policy 11.08.17l with ICD-10 code updates effective 10/01/2025. Multiple sclerosis diagnosis codes were replaced with more specific subcategories (G35.A, G35.B0-B2, G35.C0-C2, G35.D), and a new Type 2 diabetes remission code (E11.A) was added. These changes affect coverage determination for mycotic and symptomatic non-mycotic hypertrophic toenail debridement in patients with qualifying systemic illnesses.
Aetna · Identified Oct 21, 2026Medium impact
Ultrasound Therapy for Wound Healing (CPB 0746, reviewed 2026-10-16)
Aetna considers ultrasound therapy, including high-frequency ultrasound and non-contact low-frequency ultrasound devices, experimental, investigational, or unproven for wound healing and for reduction of chronic wound pain, because the effectiveness of this approach for these indications has not been established. CPT 97610, low-frequency non-contact non-thermal ultrasound per day, is listed as not covered for the indications in this policy. Examples of ultrasound therapy named in this policy include the FAST procedure, the MIST Therapy System, the Qoustic Wound Therapy System, and the Sonoca 180/185 Wound Care System.
Aetna · Identified Aug 18, 2026Medium impact
Ultrasound Therapy for Wound Healing (CPB 0746, reviewed 2025-11-26)
Aetna considers ultrasound therapy for wound healing and for reduction of chronic wound pain experimental, investigational, or unproven, because its effectiveness for these indications has not been established. This includes high-frequency ultrasound and non-contact low-frequency ultrasound devices, such as the MIST Therapy System, the Qoustic Wound Therapy System, and the Sonoca 180/185 Wound Care System. CPT 97610 is listed as not covered for the indications in this policy.
Independence Blue Cross · Effective Oct 1, 2025Low impact
11.08.17l, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails
Independence Blue Cross reissued policy 11.08.17l with no substantive coverage changes, but updated ICD-10 diagnosis codes effective 10/01/2025. Attachment B added E11.A (Type 2 diabetes in remission), Attachment C replaced generic G35 (Multiple sclerosis) with seven new MS subtype codes, and deleted the old G35 code. These are diagnostic code updates only and do not affect medical necessity criteria or billing procedures for toenail debridement.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.014g, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross reissued MA11.014g on 04/02/2025 to communicate the Company's continuing position on debridement of mycotic and symptomatic non-mycotic hypertrophic toenails. This is a policy reissuance with no material coverage changes—the same medical necessity criteria, billing codes, and ICD-10 diagnosis codes remain in effect. Billing teams should verify their systems reflect the current policy version (MA11.014h supersedes MA11.014g) and confirm all applicable diagnosis codes are captured at claim submission.
Independence Blue Cross · Identified Jun 19, 2026Low impact
11.08.17k, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails
Independence Blue Cross reissued policy 11.08.17l on 04/02/2025, communicating the company's continuing position on debridement of mycotic and symptomatic non-mycotic hypertrophic toenails. No substantive coverage criteria changes were made; this is a routine policy reissuance. Billing teams should verify they are using version 11.08.17l (the current version) rather than superseded version 11.08.17k, as the older version has been removed from the IBX portal.

Watch L02.619

Get one email when a payer policy names L02.619, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code L02.619?

There are 8 tracked policy changes affecting code L02.619, including updates from Independence Blue Cross, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code L02.619?

Payers that have issued tracked updates for code L02.619 include: Independence Blue Cross, Aetna.

How do I get notified when code L02.619 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code L02.619. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code L02.619?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails

MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails

11.08.17l, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails

Ultrasound Therapy for Wound Healing (CPB 0746, reviewed 2026-10-16)

Ultrasound Therapy for Wound Healing (CPB 0746, reviewed 2025-11-26)

11.08.17l, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails

MA11.014g, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails

11.08.17k, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails

What insurance policy changes affect code L02.619?

Which payers have updated policy for code L02.619?

How do I get notified when code L02.619 policy changes?

Why do payers change policies for code L02.619?